{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:05:17Z","timestamp":1786118717502,"version":"build-2736575974"},"reference-count":66,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1097\/mop.0b013e3280128ce8","type":"journal-article","created":{"date-parts":[[2007,3,14]],"date-time":"2007-03-14T03:51:38Z","timestamp":1173844298000},"page":"1-8","source":"Crossref","is-referenced-by-count":41,"title":["Myelodysplastic and myeloproliferative disorders in children"],"prefix":"10.1097","volume":"19","author":[{"given":"Henrik","family":"Hasle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-2-20210206","doi-asserted-by":"crossref","first-page":"620","DOI":"10.7326\/0003-4819-103-4-620","article-title":"Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group","volume":"103","author":"Bennett","year":"1985","journal-title":"Ann Intern Med"},{"key":"R3-2-20210206","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/sj.leu.2402765","article-title":"A pediatric approach to the WHO classification of myelodysplastic and myeloproliferative diseases","volume":"17","author":"Hasle","year":"2003","journal-title":"Leukemia"},{"key":"R4-2-20210206","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1002\/cncr.20910","article-title":"International Classification of Childhood Cancer, third edition","volume":"103","author":"Steliarova-Foucher","year":"2005","journal-title":"Cancer"},{"key":"R5-2-20210206","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1182\/blood-2002-11-3444","article-title":"Refractory anemia in childhood: a retrospective analysis of 67 patients with particular reference to monosomy 7","volume":"102","author":"Kardos","year":"2003","journal-title":"Blood"},{"key":"R6-2-20210206","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1097\/00043426-200210000-00028","article-title":"A practical, comprehensive classification for pediatric myelodysplastic syndromes: the CCC System","volume":"24","author":"Mandel","year":"2002","journal-title":"J Pediatr Hematol Oncol"},{"key":"R7-2-20210206","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/pbc.20174","article-title":"Comparison of two new classifications for pediatric myelodysplastic and myeloproliferative disorders","volume":"44","author":"Occhipinti","year":"2005","journal-title":"Pediatr Blood Cancer"},{"key":"R8-2-20210206","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0140-6736(99)05264-2","article-title":"Risks of leukaemia and solid tumours in individuals with Down's syndrome","volume":"355","author":"Hasle","year":"2000","journal-title":"Lancet"},{"key":"R9-2-20210206","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/01.mph.0000172223.04694.c4","article-title":"GATA1 mutation analysis demonstrates two distinct primary leukemias in a child with Down syndrome; implications for leukemogenesis","volume":"27","author":"Hellebostad","year":"2005","journal-title":"J Pediatr Hematol Oncol"},{"key":"R10-2-20210206","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/j.1365-2141.2005.05398.x","article-title":"Acute leukaemia in children with Down syndrome: a population-based Nordic study","volume":"128","author":"Zeller","year":"2005","journal-title":"Br J Haematol"},{"key":"R11-2-20210206","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/pbc.20066","article-title":"GATA1 mutations in Down syndrome: implications for biology and diagnosis of children with transient myeloproliferative disorder and acute megakaryoblastic leukemia","volume":"44","author":"Crispino","year":"2005","journal-title":"Pediatr Blood Cancer"},{"key":"R12-2-20210206","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrc1525","article-title":"Origins of leukaemia in children with Down syndrome","volume":"5","author":"Hitzler","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"R13-2-20210206","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1073\/pnas.0511150103","article-title":"Identification of distinct molecular phenotypes in acute megakaryoblastic leukemia by gene expression profiling","volume":"103","author":"Bourquin","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"R14-2-20210206","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1038\/sj.leu.2403814","article-title":"AML patients with Down syndrome have a high cure rate with AML-BFM therapy with reduced dose intensity","volume":"19","author":"Creutzig","year":"2005","journal-title":"Leukemia"},{"key":"R15-2-20210206","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/j.1365-2141.2005.05906.x","article-title":"Treatment for myeloid leukaemia of Down syndrome: population-based experience in the UK and results from the Medical Research Council AML 10 and AML 12 trials","volume":"132","author":"Rao","year":"2006","journal-title":"Br J Haematol"},{"key":"R16-2-20210206","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2141.2005.05700.x","article-title":"Optimizing therapy for myeloid disorders of Down syndrome","volume":"131","author":"Webb","year":"2005","journal-title":"Br J Haematol"},{"key":"R17-2-20210206","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00277-005-0045-5","article-title":"Optimal treatment intensity in children with Down syndrome and myeloid leukaemia: data from 56 children treated on NOPHO-AML protocols and a review of the literature","volume":"85","author":"Abildgaard","year":"2006","journal-title":"Ann Hematol"},{"key":"R18-2-20210206","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1038\/sj.leu.2403927","article-title":"Pediatric Oncology Group (POG) studies of acute myeloid leukemia (AML): a review of four consecutive childhood AML trials conducted between 1981 and 2000","volume":"19","author":"Ravindranath","year":"2005","journal-title":"Leukemia"},{"key":"R19-2-20210206","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/j.1365-2141.2006.06097.x","article-title":"Long-term results of an ultra low-dose cytarabine-based regimen for the treatment of acute megakaryoblastic leukaemia in children with Down syndrome","volume":"133","author":"Al Ahmari","year":"2006","journal-title":"Br J Haematol"},{"key":"R20-2-20210206","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1182\/blood-2005-06-2219","article-title":"Differential gene expression, GATA1 target genes, and the chemotherapy sensitivity of Down syndrome megakaryocytic leukemia","volume":"107","author":"Ge","year":"2006","journal-title":"Blood"},{"key":"R21-2-20210206","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1046\/j.1365-2141.2003.04361.x","article-title":"Paediatric MDS and JMML in the UK: a population based study of incidence and survival","volume":"121","author":"Passmore","year":"2003","journal-title":"Br J Haematol"},{"key":"R22-2-20210206","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1182\/blood.V93.2.459","article-title":"Myelodysplastic and myeloproliferative disorders of childhood: a study of 167 patients","volume":"93","author":"Luna-Fineman","year":"1999","journal-title":"Blood"},{"key":"R23-2-20210206","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1038\/sj.leu.2402271","article-title":"Myelodysplastic syndrome in childhood: a retrospective study of 189 patients in Japan","volume":"15","author":"Sasaki","year":"2001","journal-title":"Leukemia"},{"key":"R24-2-20210206","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1046\/j.1365-2141.1999.01645.x","article-title":"A population-based study of childhood myelodysplastic syndrome in British Columbia, Canada","volume":"106","author":"Hasle","year":"1999","journal-title":"Br J Haematol"},{"key":"R25-2-20210206","first-page":"707","article-title":"TERC mutations in children with refractory cytopenia","volume":"91","author":"Ortmann","year":"2006","journal-title":"Haematologica"},{"key":"R26-2-20210206","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/01.mph.0000212952.58597.84","article-title":"Low frequency of telomerase RNA mutations among children with aplastic anemia or myelodysplastic syndrome","volume":"28","author":"Field","year":"2006","journal-title":"J Pediatr Hematol Oncol"},{"key":"R27-2-20210206","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.cancergencyto.2004.02.025","article-title":"Low frequency of NRAS and KRAS2 gene mutations in childhood myelodysplastic syndromes","volume":"154","author":"Jekic","year":"2004","journal-title":"Cancer Genet Cytogenet"},{"key":"R29-2-20210206","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/j.1365-2141.2005.05392.x","article-title":"Methylation status of the p15 and p16 genes in paediatric myelodysplastic syndrome and juvenile myelomonocytic leukaemia","volume":"128","author":"Hasegawa","year":"2005","journal-title":"Br J Haematol"},{"key":"R30-2-20210206","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s00431-004-1548-0","article-title":"Myelodysplastic features in an infant with cystic fibrosis presenting with anaemia, oedema and failure to thrive","volume":"164","author":"Kratz","year":"2005","journal-title":"Eur J Pediatr"},{"key":"R31-2-20210206","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/01.mph.0000199585.98926.55","article-title":"Myeloid dysplasia in familial 3-methylglutaconic aciduria","volume":"28","author":"Haimi","year":"2006","journal-title":"J Pediatr Hematol Oncol"},{"key":"R32-2-20210206","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1097\/00043426-200312000-00008","article-title":"Hematologic features and clinical course of an infant with Pearson syndrome caused by a novel deletion of mitochondrial DNA","volume":"25","author":"Knerr","year":"2003","journal-title":"J Pediatr Hematol Oncol"},{"key":"R33-2-20210206","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s00277-005-1034-4","article-title":"Evaluation of dysplastic features in myelodysplastic syndromes: experience from the morphology group of the European Working Group of MDS in Childhood (EWOG-MDS)","volume":"84","author":"Cant\u00f9-Rajnoldi","year":"2005","journal-title":"Ann Hematol"},{"key":"R34-2-20210206","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1136\/jcp.2004.020974","article-title":"Myelodysplastic syndrome with erythroid hypoplasia","volume":"58","author":"Goyal","year":"2005","journal-title":"J Clin Pathol"},{"key":"R35-2-20210206","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1046\/j.1365-2141.2002.03369.x","article-title":"Results of treatment of children with refractory anaemia with excess blasts (RAEB) and RAEB in transformation (RAEBt) in Great Britain","volume":"117","author":"Webb","year":"2002","journal-title":"Br J Haematol"},{"key":"R36-2-20210206","first-page":"434","article-title":"Prospective study of 90 children requiring treatment for juvenile myelomonocytic leukemia or myelodysplastic syndrome: a report from the Children's Cancer Group","volume":"20","author":"Woods","year":"2002","journal-title":"J Clin Oncol"},{"key":"R37-2-20210206","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1182\/blood-2005-02-0531","article-title":"The mutational spectrum of PTPN11 in juvenile myelomonocytic leukemia and Noonan syndrome\/myelodysplastic syndromes proliferative disease","volume":"105","author":"Kratz","year":"2005","journal-title":"Blood"},{"key":"R38-2-20210206","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/pbc.20644","article-title":"Inherited predispositions and hyperactive Ras in myeloid leukemogenesis","volume":"46","author":"Lauchle","year":"2006","journal-title":"Pediatr Blood Cancer"},{"key":"R39-2-20210206","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1182\/blood.V106.11.2587.2587","article-title":"Phase II window study of the farnesyltransferase inhibitor R115777 (Zarnestra) in untreated juvenile myelomonocytic leukemia (JMML): a Childrens Oncology Group Study (ASH Annual Meeting Abstracts).","volume":"106","author":"Castleberry","year":"2005","journal-title":"Blood"},{"key":"R40-2-20210206","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/ng1748","article-title":"Germline KRAS mutations cause Noonan syndrome","volume":"38","author":"Schubbert","year":"2006","journal-title":"Nat Genet"},{"key":"R41-2-20210206","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1038\/sj.leu.2404303","article-title":"A novel somatic K-Ras mutation in juvenile myelomonocytic leukemia","volume":"20","author":"Reimann","year":"2006","journal-title":"Leukemia"},{"key":"R42-2-20210206","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1038\/sj.leu.2403489","article-title":"The International Prognostic Scoring System (IPSS) for childhood myelodysplastic syndrome (MDS) and juvenile myelomonocytic leukemia (JMML)","volume":"18","author":"Hasle","year":"2004","journal-title":"Leukemia"},{"key":"R43-2-20210206","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1182\/blood-2002-09-2867","article-title":"Antithymocyte globulin has limited efficacy and substantial toxicity in unselected anemic patients with myelodysplastic syndrome","volume":"101","author":"Steensma","year":"2003","journal-title":"Blood"},{"issue":"Suppl 1","key":"R44-2-20210206","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1038\/sj.bmt.1704836","article-title":"Stem cell transplantation for aplastic anemia and myelodysplastic syndrome","volume":"35","author":"Stary","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"R45-2-20210206","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/sj.bmt.1704438","article-title":"Allogeneic bone marrow transplantation in children with myelodysplastic syndrome or juvenile myelomonocytic leukemia: the Seattle experience","volume":"33","author":"Yusuf","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"R46-2-20210206","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/sj.bmt.1704753","article-title":"Monosomy 7 associated with pediatric acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS): successful management by allogeneic hematopoietic stem cell transplant (HSCT)","volume":"35","author":"Trobaugh-Lotrario","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"R47-2-20210206","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/sj.bmt.1702432","article-title":"Analysis of prognostic factors for allogeneic marrow transplantation following busulfan and cyclophosphamide in myelodysplastic syndrome and after leukemic transformation","volume":"25","author":"Copelan","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"R48-2-20210206","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/j.transproceed.2004.05.081","article-title":"Allogeneic hematopoietic cell transplantation from alternative donors in children with myelodysplastic syndrome: is that an alternative?","volume":"36","author":"Kalwak","year":"2004","journal-title":"Transplant Proc"},{"key":"R49-2-20210206","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1365-2141.2004.05354.x","article-title":"Children with myelodysplastic syndrome (MDS) and increasing mixed chimaerism after allogeneic stem cell transplantation have a poor outcome which can be improved by preemptive immunotherapy","volume":"128","author":"Bader","year":"2005","journal-title":"Br J Haematol"},{"key":"R50-2-20210206","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1600-0609.2004.00260.x","article-title":"WT1 gene expression: useful marker for minimal residual disease in childhood myelodysplastic syndromes and juvenile myelo-monocytic leukemia?","volume":"73","author":"Bader","year":"2004","journal-title":"Eur J Haematol"},{"key":"R51-2-20210206","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/ajh.20498","article-title":"Successful rapid discontinuation of immunosuppressive therapy at molecular relapse after allogeneic bone marrow transplantation in a pediatric patient with myelodysplastic syndrome","volume":"81","author":"Tamura","year":"2006","journal-title":"Am J Hematol"},{"key":"R52-2-20210206","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1200\/JCO.2000.18.5.963","article-title":"Allogeneic bone marrow transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia: a long-term study of 70 patients-report of the French society of bone marrow transplantation","volume":"18","author":"Yakoub-Agha","year":"2000","journal-title":"J Clin Oncol"},{"key":"R53-2-20210206","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1182\/blood.V100.2.427","article-title":"Acute myeloid leukemia and myelodysplastic syndrome in children treated for cancer: comparison with primary presentation","volume":"100","author":"Barnard","year":"2002","journal-title":"Blood"},{"key":"R54-2-20210206","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.leukres.2004.11.018","article-title":"Therapy-related myelodysplastic syndrome in childhood: a retrospective study of 36 patients in Japan","volume":"29","author":"Tsurusawa","year":"2005","journal-title":"Leuk Res"},{"key":"R55-2-20210206","doi-asserted-by":"crossref","first-page":"4628","DOI":"10.1182\/blood-2005-11-4370","article-title":"The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy","volume":"107","author":"Rosenberg","year":"2006","journal-title":"Blood"},{"key":"R56-2-20210206","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1365-2141.2005.05758.x","article-title":"Haematopoietic stem cell transplantation for Shwachman-Diamond disease: a study from the European Group for blood and marrow transplantation","volume":"131","author":"Cesaro","year":"2005","journal-title":"Br J Haematol"},{"key":"R57-2-20210206","first-page":"3534","article-title":"Chronic myelomonocytic leukemia in childhood: a retrospective analysis of 110 cases","volume":"89","author":"Niemeyer","year":"1997","journal-title":"Blood"},{"key":"R58-2-20210206","first-page":"1269","article-title":"Intensive chemotherapy in childhood myelodysplastic syndrome. A comparison with results in acute myeloid leukemia","volume":"10","author":"Hasle","year":"1996","journal-title":"Leukemia"},{"key":"R59-2-20210206","first-page":"1111","article-title":"Juvenile myelomonocytic leukemia: analyses of treatment results in the EORTC Children's Leukemia Cooperative Group (CLCG)","volume":"18","author":"Lutz","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"R60-2-20210206","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1093\/annonc\/mdi233","article-title":"Little response to zoledronic acid in a child of juvenile myelomonocytic leukemia (JMML) harboring the PTPN11 mutation","volume":"16","author":"Shimada","year":"2005","journal-title":"Ann Oncol"},{"key":"R61-2-20210206","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/01.mph.0000157381.28920.e3","article-title":"Complete remission following clofarabine treatment in refractory juvenile myelomonocytic leukemia","volume":"27","author":"Corey","year":"2005","journal-title":"J Pediatr Hematol Oncol"},{"key":"R63-2-20210206","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/sj.leu.2402407","article-title":"Allogeneic hematopoietic stem cell transplantation for 27 children with juvenile myelomonocytic leukemia diagnosed based on the criteria of the International JMML Working Group","volume":"16","author":"Manabe","year":"2002","journal-title":"Leukemia"},{"key":"R64-2-20210206","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1046\/j.0007-1048.2001.03333.x","article-title":"Unrelated donor bone marrow transplantation for children with juvenile myelomonocytic leukaemia","volume":"116","author":"Smith","year":"2002","journal-title":"Br J Haematol"},{"key":"R65-2-20210206","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1182\/blood-2004-05-1944","article-title":"Hematopoietic stem cell transplantation (HSCT) in children with juvenile myelomonocytic leukemia (JMML): results of the EWOG-MDS\/EBMT trial","volume":"105","author":"Locatelli","year":"2005","journal-title":"Blood"},{"key":"R66-2-20210206","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1200\/JCO.1997.15.2.566","article-title":"Allogeneic bone marrow transplantation for chronic myelomonocytic leukemia in childhood: a report from the European Working Group on Myelodysplastic Syndrome in Childhood","volume":"15","author":"Locatelli","year":"1997","journal-title":"J Clin Oncol"},{"key":"R67-2-20210206","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/j.1365-2141.2005.05489.x","article-title":"Chimaerism analyses and subsequent immunological intervention after stem cell transplantation in patients with juvenile myelomonocytic leukaemia","volume":"129","author":"Yoshimi","year":"2005","journal-title":"Br J Haematol"},{"key":"R68-2-20210206","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/sj.leu.2403721","article-title":"Donor leukocyte infusion after hematopoietic stem cell transplantation in patients with juvenile myelomonocytic leukemia","volume":"19","author":"Yoshimi","year":"2005","journal-title":"Leukemia"},{"key":"R69-2-20210206","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/j.1399-3046.2005.00372.x","article-title":"Three consecutive related bone marrow transplants for juvenile myelomonocytic leukaemia","volume":"9","author":"Faraci","year":"2005","journal-title":"Pediatr Transplant"}],"container-title":["Current Opinion in Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MOP.0b013e3280128ce8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:33:19Z","timestamp":1786033999000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00008480-200702000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2]]},"references-count":66,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/mop.0b013e3280128ce8","relation":{},"ISSN":["1040-8703"],"issn-type":[{"value":"1040-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2007,2]]}}}